Bibliography

Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,700 peer-reviewed publications. The CPRD bibliography is updated on a monthly basis (last updated 6 April 2021) and papers are listed below and in the PDF below.

If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.

Download:

 (PDF, 5MB, 226 pages) 

This work uses data provided by patients and collected by the NHS as part of their care and support. CPRD encourages researchers to use this citation in all publications using CPRD data. Find out more about acknowledging the use of patient data at the Understanding Patient Data website. 

 

 

Export 9 results:
Author Title [ Type(Asc)] Year
Filters: Author is Pollak, M. N.  [Clear All Filters]
Journal Article
L. Azoulay, Yin, H., Filion, K. B., Assayag, J., Majdan, A., Pollak, M. N., and Suissa, S., “The use of pioglitazone and the risk of bladder cancer in people with type 2 diabetes: nested case-control study”, Bmj, vol. 344, p. e3645, 2012.
B. B. Smiechowski, Azoulay, L., Yin, H., Pollak, M. N., and Suissa, S., “The use of metformin and the incidence of lung cancer in patients with type 2 diabetes”, Diabetes Care, vol. 36, pp. 124-9, 2013.
B. Smiechowski, Azoulay, L., Yin, H., Pollak, M. N., and Suissa, S., “The use of metformin and colorectal cancer incidence in patients with type II diabetes mellitus”, Cancer Epidemiol Biomarkers Prev, vol. 22, pp. 1877-83, 2013.
J. Assayag, Pollak, M. N., and Azoulay, L., “The use of aspirin and the risk of mortality in patients with prostate cancer”, J Urol, vol. 193, pp. 1220-5, 2015.
L. Bensimon, Yin, H., Suissa, S., Pollak, M. N., and Azoulay, L., “Type 2 diabetes and the risk of mortality among patients with prostate cancer”, Cancer Causes Control, vol. 25, pp. 329-38, 2014.
Y. Lian, Yin, H., Pollak, M. N., Carrier, S., Platt, R. W., Suissa, S., and Azoulay, L., “Phosphodiesterase Type 5 Inhibitors and the Risk of Melanoma Skin Cancer”, Eur Urol, vol. 70, pp. 808-815, 2016.
D. Abrahami, Yin, H., Yu, O. H. Y., Pollak, M. N., and Azoulay, L., “Incretin-based Drugs and the Incidence of Colorectal Cancer in Patients with Type 2 Diabetes”, Epidemiology, vol. 29, pp. 246-253, 2018.
B. M. Hicks, Yin, H., Yu, O. H., Pollak, M. N., Platt, R. W., and Azoulay, L., “Glucagon-like peptide-1 analogues and risk of breast cancer in women with type 2 diabetes: population based cohort study using the UK Clinical Practice Research Datalink”, Bmj, vol. 355, p. i5340, 2016.
J. Assayag, Yin, H., Benayoun, S., Pollak, M. N., Suissa, S., and Azoulay, L., “Androgen deprivation therapy and the risk of colorectal cancer in patients with prostate cancer”, Cancer Causes Control, vol. 24, pp. 839-45, 2013.
[Page last reviewed 6 April 2021]